I MAB's ticker is IMAB and the CUSIP is 44975P103. A total of 49 filers reported holding I MAB in Q3 2023. The put-call ratio across all filers is 1.51 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $318,610 | -63.8% | 241,371 | -18.0% | 0.00% | – |
| Q2 2023 | $880,654 | -29.1% | 294,533 | -18.0% | 0.00% | – |
| Q1 2023 | $1,242,555 | -44.2% | 359,120 | -32.6% | 0.00% | – |
| Q4 2022 | $2,225,766 | -51.2% | 532,480 | -53.2% | 0.00% | -100.0% |
| Q3 2022 | $4,565,000 | -62.6% | 1,138,338 | +5.5% | 0.00% | -66.7% |
| Q2 2022 | $12,195,000 | +3.3% | 1,079,195 | +48.5% | 0.00% | +50.0% |
| Q1 2022 | $11,801,000 | -32.0% | 726,692 | +98.3% | 0.00% | -33.3% |
| Q4 2021 | $17,365,000 | +13.8% | 366,419 | +74.0% | 0.00% | 0.0% |
| Q3 2021 | $15,264,000 | +28.9% | 210,561 | +49.3% | 0.00% | 0.0% |
| Q2 2021 | $11,843,000 | +64.4% | 141,072 | -5.1% | 0.00% | +50.0% |
| Q1 2021 | $7,203,000 | +854.0% | 148,602 | +828.4% | 0.00% | – |
| Q4 2020 | $755,000 | -71.8% | 16,007 | -71.9% | 0.00% | -100.0% |
| Q3 2020 | $2,676,000 | – | 56,906 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EDBI Pte Ltd | 222,136 | $768,591 | 0.86% |
| HHLR ADVISORS, LTD. | 6,954,442 | $24,062,369 | 0.43% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 310,499 | $1,074,327 | 0.30% |
| Maso Capital Partners Ltd | 100,000 | $346 | 0.23% |
| Artal Group S.A. | 850,000 | $2,941 | 0.18% |
| Virtus ETF Advisers LLC | 26,347 | $91,161 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 96,555 | $334 | 0.03% |
| CAXTON ASSOCIATES LP | 53,793 | $186,124 | 0.03% |
| Diametric Capital, LP | 13,924 | $48,177 | 0.02% |
| Tekla Capital Management LLC | 162,580 | $562,527 | 0.02% |